
MOU with India firm could help expand 101 biotech hub

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
FDA lifts clinical hold on Atara’s lead treatment

Thousand Oaks-based Atara Biotherapeutics received a bit of good news on May 5, after the U.S. Food and Drug Administration announced that it has lifted its hold on Atara’s active Investigational New Drug application for the Ebvallo program. Ebvallo, which is already approved in Europe and is used for transplant-related blood cancer, was placed on Read More →

805 Tech: Biotech Corridor Conference hits it out of the park for 3rd straight year

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Biotech execs forecast rapid growth for 101 corridor

The Highway 101 biotech hub will continue to grow rapidly in coming years, key industry stakeholders forecast at an April 24 life sciences forum in Westlake Village. “In the last 15 years, the 101 biotech corridor has positioned itself as a vibrant life science cluster as it has addressed issues such as lack of wet Read More →
Teledyne delivers Q1 earnings beat, announces new CEO

Thousand Oaks-based Teledyne Technologies has had an interesting end to the month of April, beating analysts’ expectations when it released its earnings on April 23 and announcing its new CEO a few days later on April 28. George C. Bobb III, who most recently served as the company’s president and COO, was elevated to president Read More →